ArticleNeurosurgical review2025
Association between intracranial vascular vulnerability and indirect revascularization development in moyamoya disease.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Distinct impact of RNF213 p.R4810K genotype on transdural collateral formation across Japanese Asian and Polish Caucasian Moyamoya patients.Neurosurgical review · 2025Article
- Successful Clazosentan Therapy for Subarachnoid Hemorrhage after Coil Embolization of Ruptured Posterior Cerebral Artery Aneurysm in a Patient with Moyamoya Disease: A Case Report.NMC case report journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Negative remodeling, characterized by a decrease in the outer diameter of cerebral arteries, is a hallmark of moyamoya disease (MMD). Postoperative fluid-attenuated inversion recovery (FLAIR) cortical hyperintensity (FCH), indicative of leptomeningeal vasogenic edema, and indirect bypass development are also distinctive features. We investigated the relationships between negative remodeling and these postoperative phenomena. We analyzed 42 hemispheres from 37 adult patients with MMD who underwent combined direct and indirect revascularization. Negative remodeling was assessed by measuring the terminal portion (C1) vessel diameter of the internal carotid artery on preoperative heavy T2-weighted images. FCH was scored from 0 to 6 based on its extent on FLAIR images obtained 2 days postoperatively; indirect bypass development was evaluated qualitatively using magnetic resonance angiography 6 months post-surgery. The participants' median age was 45 years; 76% were female and 90% presented with ischemic onset. The median C1 diameter was 2.39 mm, median FCH score was 2.5, and favorable indirect bypass development was observed in 64% of cases. Smaller preoperative C1 diameters (2.27 mm vs. 3.02 mm, p < 0.0001) and higher FCH scores (median 3 vs. 2, p < 0.05) correlated with favorable indirect bypass development. Smaller C1 diameters also aligned with extensive FCH (2.94 mm vs. 2.20 mm, p < 0.001). Multivariate analysis revealed a significant association between reduced preoperative C1 diameter and favorable indirect bypass development (odds ratio 0.019, 95% confidence interval 0.010-0.17, p < 0.01). These findings suggest that advanced intracranial vascular remodeling in MMD correlates with vascular vulnerability and favorable indirect bypass development.
Indexed as
Identifiers
40274655What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.